CASI logo

CASI Pharmaceuticals (CASI) Cash And Cash Equivalents

CASI Annual Cash & Cash Equivalents

$17.08 M
-$30.03 M-63.74%

31 December 2023

CASI Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Quarterly Cash And Cash Equivalents

$16.54 M
+$7.00 M+73.47%

01 September 2024

CASI Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-63.7%-3.2%
3 y3 years-70.1%-3.2%
5 y5 years-79.7%-3.2%

CASI Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-63.7%at low-64.9%+73.5%
5 y5-year-70.1%at low-77.8%+73.5%
alltimeall time-79.7%+1480.9%-83.4%+1430.3%

CASI Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2024
-
$16.54 M(+73.5%)
June 2024
-
$9.53 M(-21.9%)
Mar 2024
-
$12.20 M(-28.6%)
Dec 2023
$17.08 M(-63.7%)
$17.08 M(-14.5%)
Sept 2023
-
$19.98 M(+18.1%)
June 2023
-
$16.91 M(+1.9%)
Mar 2023
-
$16.59 M(-64.8%)
Dec 2022
$47.11 M(+21.7%)
$47.11 M(+76.2%)
Sept 2022
-
$26.74 M(+41.8%)
June 2022
-
$18.86 M(-35.5%)
Mar 2022
-
$29.26 M(-24.4%)
Dec 2021
$38.70 M(-32.2%)
$38.70 M(-27.1%)
Sept 2021
-
$53.13 M(-12.0%)
June 2021
-
$60.36 M(-11.4%)
Mar 2021
-
$68.12 M(+19.4%)
Dec 2020
$57.06 M(+6.4%)
$57.06 M(-23.5%)
Sept 2020
-
$74.59 M(+66.2%)
June 2020
-
$44.89 M(-16.7%)
Mar 2020
-
$53.88 M(+0.5%)
Dec 2019
$53.62 M(-36.3%)
$53.62 M(-15.2%)
Sept 2019
-
$63.24 M(-10.0%)
June 2019
-
$70.25 M(-29.6%)
Mar 2019
-
$99.73 M(+18.4%)
Dec 2018
$84.20 M(+93.6%)
$84.20 M(-14.8%)
Sept 2018
-
$98.87 M(+49.3%)
June 2018
-
$66.22 M(+32.7%)
Mar 2018
-
$49.89 M(+14.7%)
Dec 2017
$43.49 M(+60.5%)
$43.49 M(+101.0%)
Sept 2017
-
$21.64 M(-7.4%)
June 2017
-
$23.36 M(-8.5%)
Mar 2017
-
$25.53 M(-5.8%)
Dec 2016
$27.09 M(+428.0%)
$27.09 M(+12.2%)
Sept 2016
-
$24.14 M(+30.2%)
June 2016
-
$18.53 M(+32.9%)
Mar 2016
-
$13.94 M(+171.8%)
Dec 2015
$5.13 M(-51.9%)
$5.13 M(-20.1%)
Sept 2015
-
$6.42 M(-19.2%)
June 2015
-
$7.95 M(-15.9%)
Mar 2015
-
$9.46 M(-11.3%)
Dec 2014
$10.67 M(-29.5%)
$10.67 M(-9.7%)
Sept 2014
-
$11.82 M(-9.7%)
June 2014
-
$13.08 M(-7.9%)
Mar 2014
-
$14.20 M(-6.2%)
Dec 2013
$15.13 M(+88.0%)
$15.13 M(-4.7%)
Sept 2013
-
$15.87 M(-7.8%)
June 2013
-
$17.22 M(-5.7%)
Mar 2013
-
$18.27 M(+127.0%)
Dec 2012
$8.05 M(+644.9%)
$8.05 M(-8.7%)
Sept 2012
-
$8.81 M(-12.4%)
June 2012
-
$10.06 M(-11.3%)
Mar 2012
-
$11.35 M(+949.9%)
Dec 2011
$1.08 M(-77.9%)
$1.08 M(-45.6%)
Sept 2011
-
$1.99 M(-47.7%)
June 2011
-
$3.80 M(-20.8%)
Mar 2011
-
$4.80 M(-1.7%)
Dec 2010
$4.89 M
$4.89 M(-41.7%)
Sept 2010
-
$8.39 M(+4.9%)
DateAnnualQuarterly
June 2010
-
$7.99 M(-17.2%)
Mar 2010
-
$9.65 M(+52.8%)
Dec 2009
$6.31 M(-62.3%)
$6.31 M(-29.7%)
Sept 2009
-
$8.97 M(-15.2%)
June 2009
-
$10.58 M(-14.0%)
Mar 2009
-
$12.30 M(-26.5%)
Dec 2008
$16.74 M(-43.6%)
$16.74 M(+50.8%)
Sept 2008
-
$11.10 M(-32.4%)
June 2008
-
$16.42 M(+3.3%)
Mar 2008
-
$15.89 M(-46.4%)
Dec 2007
$29.68 M(+42.0%)
$29.68 M(+1.7%)
Sept 2007
-
$29.17 M(+158.7%)
June 2007
-
$11.28 M(-27.0%)
Mar 2007
-
$15.44 M(-26.1%)
Dec 2006
$20.90 M(+83.2%)
$20.90 M(-6.1%)
Sept 2006
-
$22.24 M(+64.9%)
June 2006
-
$13.49 M(-35.2%)
Mar 2006
-
$20.80 M(+82.4%)
Dec 2005
$11.41 M(-44.1%)
$11.41 M(-37.9%)
Sept 2005
-
$18.37 M(+118.3%)
June 2005
-
$8.42 M(-60.1%)
Mar 2005
-
$21.07 M(+3.1%)
Dec 2004
$20.43 M(-41.3%)
$20.43 M(+146.0%)
Sept 2004
-
$8.30 M(-38.8%)
June 2004
-
$13.56 M(-48.4%)
Mar 2004
-
$26.30 M(-24.5%)
Dec 2003
$34.81 M(+44.6%)
$34.81 M(+86.3%)
Sept 2003
-
$18.69 M(+4.5%)
June 2003
-
$17.88 M(+172.8%)
Mar 2003
-
$6.55 M(-72.8%)
Dec 2002
$24.07 M(-41.8%)
$24.07 M(+402.1%)
Sept 2002
-
$4.79 M(-57.9%)
June 2002
-
$11.37 M(-56.8%)
Mar 2002
-
$26.30 M(-36.4%)
Dec 2001
$41.39 M(+68.9%)
$41.39 M(+8.7%)
Sept 2001
-
$38.09 M(+39.4%)
June 2001
-
$27.32 M(-33.1%)
Mar 2001
-
$40.84 M(+66.7%)
Dec 2000
$24.50 M(-5.9%)
$24.50 M(-35.5%)
Sept 2000
-
$37.99 M(-24.1%)
June 2000
-
$50.05 M(+70.7%)
Mar 2000
-
$29.33 M(+12.7%)
Dec 1999
$26.03 M(-15.5%)
$26.03 M(-34.8%)
Sept 1999
-
$39.90 M(+128.0%)
June 1999
-
$17.50 M(-33.0%)
Mar 1999
-
$26.10 M(-15.3%)
Dec 1998
$30.80 M(+69.2%)
$30.80 M(-10.5%)
Sept 1998
-
$34.40 M(+9.9%)
June 1998
-
$31.30 M(+18.1%)
Mar 1998
-
$26.50 M(+45.6%)
Dec 1997
$18.20 M(-45.0%)
$18.20 M(-29.7%)
Sept 1997
-
$25.90 M(-11.9%)
June 1997
-
$29.40 M(-3.3%)
Mar 1997
-
$30.40 M(-8.2%)
Dec 1996
$33.10 M
$33.10 M(-38.0%)
Sept 1996
-
$53.40 M(-3.8%)
June 1996
-
$55.50 M(+630.3%)
Mar 1996
-
$7.60 M

FAQ

  • What is CASI Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is CASI Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is CASI Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of CASI is $17.08 M

What is the all time high annual cash & cash equivalents for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual cash & cash equivalents is $84.20 M

What is CASI Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, CASI annual cash & cash equivalents has changed by -$30.03 M (-63.74%)

What is CASI Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of CASI is $16.54 M

What is the all time high quarterly cash and cash equivalents for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly cash and cash equivalents is $99.73 M

What is CASI Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, CASI quarterly cash and cash equivalents has changed by -$546.00 K (-3.20%)